Johnson & Johnson (JNJ)
3 Safe Stocks with Safe Dividends for Your Portfolio
The stock market can feel like a roller coaster, especially during economic uncertainty. As fears of a recession increase, investors seek stability and look for investments that can weather the storm and offer a sense of security.
Top 3 recession-proof stocks to buy as US monthly jobs data disappoints again
The US nonfarm payrolls grew sharply on a month-over-month basis in August but still came in below the consensus forecast on Friday. The US economy added 142,000 jobs last month versus 89,000 in July and 161,000 that the Dow Jones estimate had called for.
Johnson & Johnson (JNJ) Wells Fargo 2024 Healthcare Conference (Transcript)
Johnson & Johnson (NYSE:JNJ ) Wells Fargo 2024 Healthcare Conference September 5, 2024 11:00 AM ET Company Participants Tim Schmid - Executive Vice President, Worldwide Chairman of MedTech Jessica Moore - Vice President of Investor Relations Tracy Menkowski - Senior Director of Investor Relations Conference Call Participants Larry Biegelsen - Wells Fargo Larry Biegelsen Barry, we're ready? All right, good morning.
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Worried About a Stock Market Crash: Buy These 2 Stocks Now
If you're just a bit more worried about a market sell-off going into the fourth quarter, you're not alone.
2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem
Dividend cuts and suspensions can come suddenly and investors should always be on the lookout for warning signs. A strong track record for dividend growth is by no means a guarantee that a company will pay and increase its dividend in the future.
Johnson & Johnson wins over longtime holdout for talc settlement, WSJ reports
Johnson & Johnson is expected to secure more votes in favor of its talc settlement plan after increasing its offer to claimants, which has swayed a longtime legal adversary, WSJ reported on Wednesday, citing people familiar with the matter.
Johnson & Johnson (JNJ) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
Johnson & Johnson (NYSE:JNJ ) Morgan Stanley 22nd Annual Global Healthcare Conference September 4, 2024 10:45 AM ET Company Participants Joaquin Duato - CEO & Chairman John Reed - Head of Pharma R&D Conference Call Participants Terence Flynn - Morgan Stanley Terence Flynn Great. All right.
3 Dividend Stocks to Double Up on Right Now
Verizon offers a high-yielding and steadily rising dividend. Johnson & Johnson pays a very healthy dividend.
Johnson & Johnson (JNJ) Increases Despite Market Slip: Here's What You Need to Know
Johnson & Johnson (JNJ) concluded the recent trading session at $167.16, signifying a +0.78% move from its prior day's close.
Is Johnson & Johnson the Best Dividend Stock for You?
Johnson & Johnson is a remarkably consistent business. A fortress-like balance sheet all but guarantees the dividend's safety.
JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab
The Johnson & Johnson filing seeks the FDA's approval for nipocalimab to treat generalized myasthenia gravis in a broad population of antibody-positive patients.
